{
  "scenarios": [
    {
      "id": "hiv_im_decile3_prep_lowshare",
      "therapeuticArea": "HIV",
      "hcpProfile": "Internal Medicine MD",
      "title": "Low Descovy share with missed PrEP opportunity",
      "summary": "Decile 3 IM prescriber underutilizes PrEP despite steady STI testing in young MSM; inconsistent quarterly labs and follow-ups.",
      "objection": "Clinic believes few true PrEP candidates; renal safety and monitoring workload concerns.",
      "goal": "Create urgency around PrEP gaps; commit to proactive Descovy prescribing where appropriate and standardize quarterly follow-ups.",
      "approach": "Quantify risk pool from STI volume, review renal safety data, and propose nurse-led PrEP/lab cadence."
    },
    {
      "id": "hiv_np_decile10_highshare_access",
      "therapeuticArea": "HIV",
      "hcpProfile": "Nurse Practitioner",
      "title": "High Descovy share but access and staffing barriers",
      "summary": "Decile 10 NP with strong share; prior-auth workload and workflow friction limit breadth of appropriate prescribing.",
      "objection": "Prior-auth burden and limited staffing.",
      "goal": "Broaden appropriate Descovy use via predictable PA batching and support roles; revisit generic TDF users with unrestricted coverage.",
      "approach": "Implement twice-weekly PA batching with pharmacy partner and benefits checks."
    },
    {
      "id": "hiv_pa_decile9_treat_switch_slowdown",
      "therapeuticArea": "HIV",
      "hcpProfile": "Physician Assistant",
      "title": "Slowing Biktarvy switches in stable patients",
      "summary": "Top HIV clinic; prior switch velocity fell to 1–2 in 13 weeks; perception that most patients are optimized.",
      "objection": "Reluctance to switch stable patients.",
      "goal": "Reinforce durability and convenience; define clear switch criteria and run quarterly optimization review.",
      "approach": "Create candidate list by labs/adherence flags; schedule switch day with counseling script."
    },
    {
      "id": "hiv_np_decile5_cab_growth",
      "therapeuticArea": "HIV",
      "hcpProfile": "Nurse Practitioner",
      "title": "Favoring cabotegravir/rilpivirine without uniform screening",
      "summary": "CAB share growing; NP often honors requests without systematic adherence/resistance evaluation.",
      "objection": "Patient demand driving selection; uncertainty about resistance and monitoring.",
      "goal": "Align on candidacy and monitoring criteria; protect long-term regimen durability.",
      "approach": "Adopt checklist for eligibility, resistance history, and missed-dose plan; schedule injection calendar."
    },

    {
      "id": "hiv_im_decile4_prep_apretude_gap",
      "therapeuticArea": "HIV",
      "hcpProfile": "Internal Medicine MD",
      "title": "Low Apretude vs TDF/FTC and Descovy",
      "summary": "PrEP mix skewed to orals; PA backlog; missing standing lab protocol; misconceptions about long-acting adherence.",
      "objection": "Belief that long-acting requires near-perfect adherence; operational friction.",
      "goal": "Offer Apretude to adherence-challenged candidates and convert high-risk TDF/FTC users with renal risk to Descovy where access allows.",
      "approach": "Nurse-led lab/injection calendar and PA batching; education on initiation and follow-up cadence."
    },
    {
      "id": "hiv_np_decile9_prep_ops_cap",
      "therapeuticArea": "HIV",
      "hcpProfile": "Nurse Practitioner",
      "title": "Strong PrEP program but operationally capped",
      "summary": "FQHC with high demand; PA burden caps TAF/Apretude; ad-hoc pharmacy engagement.",
      "objection": "Throughput and PA workload.",
      "goal": "Batch PAs with pharmacy tech support; monthly Apretude start day; default naive high-risk starts appropriately.",
      "approach": "Standing process for benefits checks and clinic event template."
    },
    {
      "id": "hiv_pa_decile7_treat_switch_day",
      "therapeuticArea": "HIV",
      "hcpProfile": "Physician Assistant",
      "title": "Treatment optimization day for switches",
      "summary": "Hospital-affiliated ID clinic; few recent switches; CAB/RPV interest among adherent younger patients.",
      "objection": "Perception of optimization; uncertainty on candidacy.",
      "goal": "Define CAB/RPV candidacy and counseling; track suppression and missed-dose events.",
      "approach": "Quarterly optimization clinic with resistance review and tracking."
    },

    {
      "id": "onc_md_decile10_io_adc_pathways",
      "therapeuticArea": "Oncology",
      "hcpProfile": "Medical Oncologist",
      "title": "IO-backbone heavy; ADC toxicity bandwidth",
      "summary": "Solid-tumor center evaluating ADCs; P&T scrutinizes cost/response and chair time; toxicity bandwidth is constraint.",
      "objection": "Toxicity management resources and pathway integration.",
      "goal": "Define biomarker-driven subset with ΔOS/ΔPFS and operational fit; add to order sets/tumor board.",
      "approach": "Present subset data and AE mitigation plan; align with NCCN category of evidence."
    },
    {
      "id": "onc_np_decile6_pathway_ops",
      "therapeuticArea": "Oncology",
      "hcpProfile": "Oncology NP",
      "title": "Pathway-driven care with staffing constraints",
      "summary": "Community infusion site; conservative IO use; AE clinics short-staffed; education packets inconsistent.",
      "objection": "Staffing and pathway paperwork burden.",
      "goal": "Standardize NP-led education and toxicity call-tree; add AE one-pager to pathway handouts.",
      "approach": "Template kits and standing nurse protocols."
    },
    {
      "id": "onc_pa_decile7_gu_oral_onc_tminus7",
      "therapeuticArea": "Oncology",
      "hcpProfile": "Oncology PA (GU)",
      "title": "Oral oncolytic onboarding at T-7",
      "summary": "GU team struggles with hub forms and day-25–30 refill gaps.",
      "objection": "Fragmented onboarding and late hub enrollment.",
      "goal": "Adopt T-7 onboarding with early hub, benefits check, and day-10 toxicity tele-visit.",
      "approach": "Checklist-driven onboarding and refill safeguards."
    },

    {
      "id": "vac_id_decile8_adult_flu_playbook",
      "therapeuticArea": "Vaccines",
      "hcpProfile": "Infectious Disease Specialist",
      "title": "Adult flu program underperforming",
      "summary": "ID group with LTC/high-risk adults; late clinic launches; weak reminder-recall; coverage fell in 65+.",
      "objection": "Scheduling and outreach gaps; denials in 65+ formulations.",
      "goal": "Pre-book age-appropriate mix; schedule early clinics; SMS reminders; standing orders in LTC.",
      "approach": "Calendarized clinic days and EHR prompts for 65+ high-dose/adjuvanted selection."
    },
    {
      "id": "vac_np_decile5_primary_care_capture",
      "therapeuticArea": "Vaccines",
      "hcpProfile": "Family Medicine NP",
      "title": "Primary care capture with fragmented workflows",
      "summary": "Adequate storage; VIS misses due to staff rotation; ad-hoc Saturday clinics.",
      "objection": "Workflow inconsistency and documentation misses.",
      "goal": "Standing orders, huddle checklists, and fixed weekend clinics.",
      "approach": "EHR prompts and standardized VIS documentation."
    },
    {
      "id": "vac_pa_decile6_oh_campus_outreach",
      "therapeuticArea": "Vaccines",
      "hcpProfile": "Physician Assistant (Occupational Health)",
      "title": "Employer and college outreach alignment",
      "summary": "High uptake in HCWs, low in students; inventory turns slow due to late campus events.",
      "objection": "Late campus scheduling and inventory drag.",
      "goal": "Campus pop-ups tied to orientation/midterms; redistribute excess to employer sites by week 6.",
      "approach": "Pre-registration and inventory rebalancing playbook."
    },

    {
      "id": "covid_pulm_md_decile9_antiviral_ddi_path",
      "therapeuticArea": "COVID-19",
      "hcpProfile": "Pulmonologist",
      "title": "Outpatient antivirals under-utilized",
      "summary": "High-risk COPD/ILD population; Paxlovid first line; 3-day IV remdesivir limited by capacity; DDI triage slows prescribing.",
      "objection": "DDI complexity and infusion capacity.",
      "goal": "Rapid DDI triage and standing infusion slot; 48-hour initiation KPI.",
      "approach": "Protocol for DDI screen and partner infusion scheduling."
    },
    {
      "id": "covid_pulm_np_decile6_postcovid_adherence",
      "therapeuticArea": "COVID-19",
      "hcpProfile": "Pulmonary NP",
      "title": "Post-COVID clinic adherence issues",
      "summary": "Eligible patients present day 4–5; callbacks delay start; variable education on rebound.",
      "objection": "Delayed initiation and inconsistent counseling.",
      "goal": "Same-day eRx template; patient one-pager; route day-2 positives to NP tele-start.",
      "approach": "Standardized education and expedited routing."
    },
    {
      "id": "covid_pulm_pa_decile5_hospital_at_home",
      "therapeuticArea": "COVID-19",
      "hcpProfile": "Pulmonary PA",
      "title": "Hospital-at-home linkage for antivirals",
      "summary": "Discharges qualify for outpatient therapy but lack transport for IV remdesivir; home-infusion underused.",
      "objection": "Access to infusion after discharge.",
      "goal": "Default home-infusion referral for remdesivir day 1–3 when Paxlovid contraindicated; track 7-day readmissions.",
      "approach": "Discharge checklist and vendor referral workflow."
    },

    {
      "id": "cv_card_md_decile10_hf_gdmt_uptake",
      "therapeuticArea": "Cardiovascular",
      "hcpProfile": "Cardiologist",
      "title": "HFrEF clinic with uneven GDMT adoption",
      "summary": "Entresto uptake 62% of eligible HFrEF; SGLT2 at 38%; fellows handle PAs; day-30 refill gaps.",
      "objection": "Copays, PA friction, and handoffs to PCP.",
      "goal": "Discharge GDMT checklist; pharmacy tech enrollment for copay help; +10pp SGLT2 in 90 days and halve 30-day gaps.",
      "approach": "Start SGLT2 before discharge when eligible; convert ACE/ARB to ARNI within 48–72h per protocol."
    },
    {
      "id": "cv_np_decile6_ckd_sglt2_calendar",
      "therapeuticArea": "Cardiovascular",
      "hcpProfile": "Cardiology NP",
      "title": "Rural HF program with renal concerns",
      "summary": "SGLT2 underused in CKD stage 3 due to misconceptions; no titration calendar.",
      "objection": "CKD safety misconceptions and calendar gaps.",
      "goal": "Implement titration calendar and CKD-safe counseling; track eGFR and UACR at baseline and 12 weeks.",
      "approach": "Standardize initiation with sick-day rules and follow-up labs."
    },
    {
      "id": "cv_pa_decile7_postmi_transitions",
      "therapeuticArea": "Cardiovascular",
      "hcpProfile": "Cardiology PA",
      "title": "Post-MI and HF transitions program",
      "summary": "SGLT2 initiation often deferred to PCP; ARNI starts delayed pending echo; readmissions above benchmark.",
      "objection": "Deferrals and delayed titration.",
      "goal": "Start SGLT2 prior to discharge and convert to ARNI within 48–72h; pharmacy follow-up day 7.",
      "approach": "Transition checklist with accountable owners."
    }
  ]
}
